AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
News
Predicting Purpose in 2024
January 03, 2024 01:30 AM AEDT| By 3BLIn the ever-evolving business landscape, the state of purpose has faced significant challenges over the past year, many that have led to troubling ramifications. The politicization of the term “ESG” h...
4 EV Technologies To Watch at CES 2024
January 03, 2024 01:15 AM AEDT| By 3BLEvery year, the technology industry flock to Las Vegas to attend the Consumer Electronics Show (CES) where they unveil their breakthrough innovation and explore the challenges, opportunities, and poli...
Innovative Smart Sports and Digital Health Tech From ITRI Debut at CES 2024
January 03, 2024 01:00 AM AEDT| By CisionLAS VEGAS, Jan. 2, 2024 /PRNewswire/ -- The Industrial Technology Research Institute (ITRI), Taiwan's largest and one of the world's leading high-tech applied research institutions, today...
Fairmonde Golf Welcomes LPGA Star Angel Yin as a Shareholder in a Groundbreaking Investment
January 03, 2024 01:00 AM AEDT| By CisionEco-friendly Golf Apparel Brand for Women Gains Momentum with Strategic Investment and Endorsement SHERIDAN, Wyo., Jan. 2, 2024 /PRNewswire/ -- Fairmonde Golf, a trailblazer in sustainable golf clothi...
MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche to develop next-generation antibody drug conjugate in Oncology
January 03, 2024 01:00 AM AEDT| By CisionSUZHOU, China, Jan. 2, 2024 /PRNewswire/ -- MediLink Therapeutics ("MediLink"), announced today that it has entered into a worldwide collaboration and license agreement with Roch...
Webull Launches in Canada
January 03, 2024 01:00 AM AEDT| By CisionAward-winning app expands into new market, allowing Canadians to trade Canadian- and US-listed equities at a low cost TORONTO, Jan. 2, 2024 /PRNewswire/ -- Webull Corporation, the owner o...
Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca
January 03, 2024 01:00 AM AEDT| By CisionNATICK, Mass., Jan. 2, 2024 /PRNewswire/ -- Allorion Therapeutics ("Allorion"), a US and China-based biotechnology company that focuses on the discovery of new small molecule drugs fo...
Artificial Intelligence Driving Quality Control Machine Vision Market to US$7.2 Billion by 2028
January 03, 2024 12:30 AM AEDT| By CisionNEW YORK, Jan. 2, 2024 /PRNewswire/ -- Machine Vision (MV) Solutions for quality control in manufacturing are becoming ever more essential for manufacturers due to increased regulatory req...
The Path Ahead: Getting to Know One Another Better
January 03, 2024 12:13 AM AEDT| By CisionBEIJING, Jan. 2, 2024 /PRNewswire/ -- A news report from China Daily about Youth Power: China's doors are opening even wider to the world, with connections among Gen Zers growing stronger. Whether the...
JJ's House Joins Forces with Sisters in the Fight Breast Cancer Foundation to Make Survivors Feel Beautiful
January 03, 2024 12:00 AM AEDT| By CisionNEW YORK, Jan. 2, 2024 /PRNewswire/ -- JJ's House, the renowned global online retailer specializing in wedding, occasion, prom, and party dresses, proudly announces its partnership with the Siste...
Novel Device Facilitates Successful No-Shave FUE Transplants for Long Hair with Ease
January 03, 2024 12:00 AM AEDT| By CisionLOS ANGELES, Jan. 2, 2024 /PRNewswire/ -- A recent study published in the Clinical, Cosmetic and Investigational Dermatology journal reveals a groundbreaking advancement in hair transplantation...
YolTech Therapeutics to Present and Unveil Major Progress at Biotech Showcase 2024
January 02, 2024 11:30 PM AEDT| By CisionSHANGHAI, Jan. 2, 2024 /PRNewswire/ -- YolTech Therapeutics, a biotech company developing in vivo gene editing therapies to treat rare genetic diseases, recently announced that it will present an over...
Pulnovo Medical Announces PADN Receives FDA HUD Designation and US CMS Medicare Coverage Code and NMPA Approval
January 02, 2024 11:30 PM AEDT| By CisionSHANGHAI, Jan. 2, 2024 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), recently announced that it...
JW Therapeutics Announces Exclusive Collaboration with 2seventy bio for Autoimmune Disease CAR-T Therapy
January 02, 2024 11:15 PM AEDT| By CisionSHANGHAI, Jan. 2, 2024 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy pr...
Bybit's 5th Anniversary: #High5Bybit and Record-Breaking Trading Celebration
January 02, 2024 11:12 PM AEDT| By CisionDUBAI, UAE, Jan. 2, 2024 /PRNewswire/ -- Bybit, the world's third-largest crypto exchange by volume, is proud to announce the outstanding success of its fifth-anniversary celebration event...
Gannex Announces Positive Interim Results from 52-Week Phase II Clinical Trial of Once-Daily ASC41 Tablet in Patients with Biopsy-Confirmed Non-alcoholic Steatohepatitis
January 02, 2024 11:06 PM AEDT| By Cision--Up to 68.2% mean relative reduction in liver fat content from baseline in biopsy-confirmed non-alcoholic steatohepatitis (NASH) patients receiving 12-week treatment of ASC41 tablet --At Week 12, up...
IAA Announce Its’ Latest Addition for Design Excellence – the 2024 NY Architectural Design Awards
January 02, 2024 10:58 PM AEDT| By EIN Presswire2024 NY Architectural Design Awards Call for Entries 2024 NY Awards Statuettes - Gold & Silver Commencing 2024 with a strong start, IAA now introduces the NY Architectural Design Awards, recognizi...
Beyond Accommodation - Aryaduta Hotels Sets the Bar for Culturally-Rich Experiences in Indonesia
January 02, 2024 10:51 PM AEDT| By CisionJAKARTA, Indonesia, Jan. 2, 2024 /PRNewswire/ -- Aryaduta Hotels is thrilled to announce an ongoing series of global events and campaigns with a unique focus on providing culturally rich experien...
Founder Securities rates Baguio (1397.HK) as 'Strongly Recommended' with a HK$1.10 target price, indicating a 57% upside
January 02, 2024 10:03 PM AEDT| By CisionHONG KONG, Jan. 2, 2024 /PRNewswire/ -- Founder Securities has issued a research report on Baguio Green Group (1397.HK), assigning a 'Strongly Recommended' rating and a target price of HK$1.10. T...
Shanghai launches new online portal for expat services
January 02, 2024 09:30 PM AEDT| By CisionBEIJING, Jan. 2, 2024 /PRNewswire/ -- A news report from chinadaily.com.cn: jwplayer.key="3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=" jwplayer('myplayer1').setup({file: 'https://m...
Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.